Skip to main content
. 2023 Sep 5;63(6):1656–1663. doi: 10.1093/rheumatology/kead461

Table 3.

Clinical evidence regarding treatment with methotrexate in AOSD

Author Drug Design No. of patients Reference
Fautrel et al. MTX Retrospective, uncontrolled 26 [37]
Kalyonku et al. MTX Prospective multicentre 202 [38]
Pay et al. MTX Retrospective multicentre 61 [39]
Iliou et al. MTX Retrospective, uncontrolled 11 [40]
Franchini et al. MTX Retrospective monocentre 27 (five combination of DMARDs) [41]
Fuji et al. MTX Retrospective monocentre 13 [42]
Singh et al. MTX Retrospective 10 [43]
Nordström et al. MTX RCT 6 [44]
Woo et al. MTX RCT 45 [45]
Aydintug et al. MTX Case series 6 [46]
Manger et al. MTX Review 71 [47]
Wang et al. MTX Prospective 28 [54]

AOSD: adult-onset Still’s disease.